Compare HWC & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HWC | BRKR |
|---|---|---|
| Founded | 1883 | 1960 |
| Country | United States | United States |
| Employees | 3658 | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 6.7B |
| IPO Year | N/A | 2000 |
| Metric | HWC | BRKR |
|---|---|---|
| Price | $74.44 | $60.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 13 |
| Target Price | ★ $77.67 | $48.54 |
| AVG Volume (30 Days) | 932.2K | ★ 2.9M |
| Earning Date | 04-21-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.00% | 0.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | $11.59 | $6.30 |
| Revenue Next Year | $4.42 | $3.81 |
| P/E Ratio | ★ $12.48 | $3,044.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $54.05 | $28.53 |
| 52 Week High | $75.43 | $64.54 |
| Indicator | HWC | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 66.91 | 65.30 |
| Support Level | $66.24 | $46.84 |
| Resistance Level | $75.43 | $64.54 |
| Average True Range (ATR) | 1.51 | 2.45 |
| MACD | 0.31 | -0.12 |
| Stochastic Oscillator | 80.62 | 81.89 |
Hancock Whitney Corp operates bank offices and financial centers. The company offers a range of traditional and online banking services to commercial, small business, and retail customers, providing a variety of transaction and savings deposit products, treasury management services, secured and unsecured loan products (including revolving credit facilities), letters of credit, and similar financial guarantees. The Bank provides trust and investment management services to retirement plans, corporations, and individuals and provides its customers access to investment advisory and brokerage products.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.